These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30233431)

  • 1. Neurometabolite Levels in Alcohol Use Disorder Patients During Baclofen Treatment and Prediction of Relapse to Heavy Drinking.
    Morley KC; Lagopoulos J; Logge W; Chitty K; Baillie A; Haber PS
    Front Psychiatry; 2018; 9():412. PubMed ID: 30233431
    [No Abstract]   [Full Text] [Related]  

  • 2. Moderation of baclofen response by a GABA
    Morley KC; Luquin N; Baillie A; Fraser I; Trent RJ; Dore G; Phung N; Haber PS
    Addiction; 2018 Dec; 113(12):2205-2213. PubMed ID: 29968397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.
    Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E
    Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain GABA levels are reduced in alcoholic liver disease: A proton magnetic resonance spectroscopy study.
    Morley KC; Lagopoulos J; Logge W; Baillie A; Adams C; Haber PS
    Addict Biol; 2020 Jan; 25(1):e12702. PubMed ID: 30561840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose baclofen attenuates insula activation during anticipatory anxiety in treatment-seeking alcohol dependant individuals: Preliminary findings from a pharmaco-fMRI study.
    Morley KC; Logge WB; Fraser I; Morris RW; Baillie AJ; Haber PS
    Eur Neuropsychopharmacol; 2021 May; 46():28-36. PubMed ID: 33735709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized open-label trial of baclofen for relapse prevention in alcohol dependence.
    Gupta M; Verma P; Rastogi R; Arora S; Elwadhi D
    Am J Drug Alcohol Abuse; 2017 May; 43(3):324-331. PubMed ID: 27808555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic-pituitary-adrenocortical response in alcohol-dependent patients during baclofen treatment and association with clinical outcome: Preliminary results.
    Logge W; Hurzeler T; Arunogiri S; Towers E; Baillie A; Haber PS; Morley K
    Alcohol; 2023 Nov; 112():25-29. PubMed ID: 37244449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baclofen as add-on to standard psychosocial treatment for alcohol dependence: a randomized, double-blind, placebo-controlled trial with 1 year follow-up.
    Ponizovsky AM; Rosca P; Aronovich E; Weizman A; Grinshpoon A
    J Subst Abuse Treat; 2015 May; 52():24-30. PubMed ID: 25572706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations Between Recent Heavy Drinking and Dorsal Anterior Cingulate N-Acetylaspartate and Glutamate Concentrations in Non-Treatment-Seeking Individuals with Alcohol Dependence.
    Prisciandaro JJ; Schacht JP; Prescot AP; Renshaw PF; Brown TR; Anton RF
    Alcohol Clin Exp Res; 2016 Mar; 40(3):491-6. PubMed ID: 26853538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain Glutamate, GABA, and Glutamine Levels and Associations with Recent Drinking in Treatment-Naïve Individuals with Alcohol Use Disorder Versus Light Drinkers.
    Prisciandaro JJ; Schacht JP; Prescot AP; Renshaw PF; Brown TR; Anton RF
    Alcohol Clin Exp Res; 2019 Feb; 43(2):221-226. PubMed ID: 30537347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Baclofen to Explore GABA-B Receptor Function in Alcohol Dependence: Insights From Pharmacokinetic and Pharmacodynamic Measures.
    Durant CF; Paterson LM; Turton S; Wilson SJ; Myers JFM; Muthukumaraswamy S; Venkataraman A; Mick I; Paterson S; Jones T; Nahar LK; Cordero RE; Nutt DJ; Lingford-Hughes A
    Front Psychiatry; 2018; 9():664. PubMed ID: 30618857
    [No Abstract]   [Full Text] [Related]  

  • 12. Sex as a Potential Moderator for Baclofen Response in the Treatment of Alcohol Dependence.
    Morley KC; Louie E; Hurzeler T; Baillie A; Dore G; Phung N; Haber PS
    Front Glob Womens Health; 2022; 3():807269. PubMed ID: 35425938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis.
    Rose AK; Jones A
    Addiction; 2018 Aug; 113(8):1396-1406. PubMed ID: 29479827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baclofen for alcohol dependence: a preliminary open-label study.
    Flannery BA; Garbutt JC; Cody MW; Renn W; Grace K; Osborne M; Crosby K; Morreale M; Trivette A
    Alcohol Clin Exp Res; 2004 Oct; 28(10):1517-23. PubMed ID: 15597084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baclofen Response in Alcohol Dependent Patients Concurrently Receiving Antidepressants: Secondary Analysis From the BacALD Study.
    Heng S; Jamshidi N; Baillie A; Louie E; Dore G; Phung N; Haber PS; Morley KC
    Front Psychiatry; 2018; 9():576. PubMed ID: 30524317
    [No Abstract]   [Full Text] [Related]  

  • 16. Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial.
    Morley KC; Baillie A; Fraser I; Furneaux-Bate A; Dore G; Roberts M; Abdalla A; Phung N; Haber PS
    Br J Psychiatry; 2018 Jun; 212(6):362-369. PubMed ID: 29716670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.
    Addolorato G; Caputo F; Capristo E; Domenicali M; Bernardi M; Janiri L; Agabio R; Colombo G; Gessa GL; Gasbarrini G
    Alcohol Alcohol; 2002; 37(5):504-8. PubMed ID: 12217947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal proton magnetic resonance spectroscopy study investigating oxidative stress as a result of alcohol and tobacco use in youth with bipolar disorder.
    Chitty KM; Lagopoulos J; Hickie IB; Hermens DF
    J Affect Disord; 2015 Apr; 175():481-7. PubMed ID: 25679204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.
    Palpacuer C; Duprez R; Huneau A; Locher C; Boussageon R; Laviolle B; Naudet F
    Addiction; 2018 Feb; 113(2):220-237. PubMed ID: 28940866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Predictors of Response to Baclofen in the Treatment of Alcohol use Disorder: Results from the BacALD Trial.
    Rombouts SA; Baillie A; Haber PS; Morley KC
    Alcohol Alcohol; 2019 May; 54(3):272-278. PubMed ID: 30977770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.